Suppr超能文献

不使用眼科粘弹剂的人工晶状体植入术

Intraocular lens implantation without the use of ophthalmic viscosurgical device.

作者信息

Unsal Ugur, Baser Gonen, Soyler Mehmet

机构信息

Batigoz Eye Health Center, Sair Esref Blv 1371 Sok. No: 9, Cankaya, 35210, Izmir, Turkey.

Ozel Deniz Hospital, Izmir, Turkey.

出版信息

Int Ophthalmol. 2017 Feb;37(1):25-30. doi: 10.1007/s10792-016-0211-x. Epub 2016 Mar 14.

Abstract

The purpose of this study was to determine whether single-piece hydrophilic acrylic intraocular lens can be safely implanted without the use of ophthalmic viscosurgical devices. This retrospective study comprised 100 eyes having phacoemulsification and intraocular lens implantation without the use of ophthalmic viscosurgical device. 80 eyes with the use of a viscosurgical device are used as control group. In this intraocular lens implantation technique, the anterior chamber was maintained with an irrigation cannula and intraocular lens was implanted with a lens injector. Visual acuity, corneal clarity and edema, intraocular pressure, and corneal endothelial cell count were evaluated preoperatively and postoperatively at days 1, 7, and 30. Corneal endothelial cell count was repeated 2 weeks after surgery. Complications of this technique were also evaluated. No significant complications of this intraocular lens implantation technique, such as posterior capsule rupture, intraocular lens buttonholing, zonular dialysis, Descemet's tear/detachment, occurred. On the seventh postoperative day, 90 % of eyes achieved 20/20 or better vision. There was no difference in corneal endothelial cell loss between viscoelastic device-used and not-used cases (p = 0.356). When implanting intraocular lens without the use of ophthalmic viscosurgical device, significant intraoperative complications did not occur. The possible advantages are shortened surgery time, avoidance of postoperative IOP spike from ocular viscosurgical device (OVD) remnant, and reduced cost.

摘要

本研究的目的是确定在不使用眼科粘弹手术器械的情况下,单片式亲水性丙烯酸人工晶状体是否能够安全植入。这项回顾性研究纳入了100例行超声乳化白内障吸除术及人工晶状体植入术且未使用眼科粘弹手术器械的患眼。将80例使用了粘弹手术器械的患眼作为对照组。在这种人工晶状体植入技术中,通过灌注套管维持前房,并使用晶状体注射器植入人工晶状体。在术前以及术后第1天、第7天和第30天评估视力、角膜清晰度和水肿、眼压以及角膜内皮细胞计数。术后2周重复测量角膜内皮细胞计数。还对该技术的并发症进行了评估。这种人工晶状体植入技术未出现诸如后囊破裂、人工晶状体纽扣孔形成、悬韧带离断、后弹力层撕裂/脱离等严重并发症。术后第7天,90%的患眼视力达到20/20或更好。使用与未使用粘弹性装置的病例在角膜内皮细胞损失方面无差异(p = 0.356)。在不使用眼科粘弹手术器械植入人工晶状体时,未发生严重的术中并发症。可能的优势包括手术时间缩短、避免因眼科粘弹剂残留导致的术后眼压峰值以及成本降低。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验